返回产品
威格顿生物 徐州威格顿生物科技有限公司
威格顿生物
威格顿生物 Weigedun Biotechnology
产品说明书

LILRB2 Mouse mAb

货号WGD-Z-2611810 更新日期2026-08-29
规格信息
规格货号
50ul WGD-Z-2611810
100ul WGD-Z-2611810
详细参数
别名 Leukocyte immunoglobulin-like receptor subfamily B member 2; LIR-2; Leukocyte immunoglobulin-like receptor 2; CD85 antigen-like family member D; Immunoglobulin-like transcript 4; ILT-4; Monocyte/macrophage immunoglobulin-like receptor 10; MIR-10; CD antigen CD85d
基因名 LILRB2
UniProt ID Q8N423
反应种属 Human
应用 WB,IP,CHIP
宿主 Mouse
偶联物 Unconjugated
修饰 Unmodified
亚型 IgG2a
克隆号 7B6-V9-X1
克隆性 Monoclonal Antibody
分子量 Calculated MW: 65 kDa
纯化方式 Affinity Purified
产品形式 Liquid
推荐稀释比 WB-1:1000; IP-1:100; CHIP-1:100
存储缓冲液 Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.09% sodium azide
保存温度 Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
背景信息 Leukocyte immunoglobulin like receptor B2 (LILRB2) is an inhibitory receptor predominantly expressed on myeloid cells, including monocytes, dendritic cells, and macrophages. It features four extracellular Ig-like domains and a cytoplasmic tail containing immunoreceptor tyrosine-based inhibitory motifs (ITIMs) that recruit phosphatases such as SHP-1 and SHP-2 to dampen immune signaling. LILRB2 binds a broad spectrum of classical and non-classical MHC class I molecules, including HLA-G, to promote immune tolerance. Beyond its role in the immune system, LILRB2 acts as a receptor for beta-amyloid oligomers, contributing to synaptic plasticity impairment in Alzheimer's disease. It is also implicated in the progression of acute myeloid leukemia, where it modulates the tumor microenvironment to favor immune evasion.